23Andme Holding Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

23Andme Holding Stock Summary

23Andme Holding competes with IDEXX Laboratories, Twist Bioscience, Guardant Health, Agilent Technologies, and Thermo Fisher. 23andMe Holding Co. operates as a consumer genetics testing company. The company was founded in 2006 and is headquartered in South San Francisco, California. 23Andme Holding is traded on NASDAQ Exchange in the United States.

23Andme Holding Key Financial Ratios

23Andme Holding Key Balance Sheet Accounts

23Andme Holding Key Income Statement Accounts

23Andme Holding Key Cash Accounts

23Andme Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining 23Andme Holding's current stock value. Our valuation model uses many indicators to compare 23Andme Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 23Andme Holding competition to find correlations between indicators driving 23Andme Holding's intrinsic value. More Info.23Andme Holding Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, 23Andme Holding's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value 23Andme Holding by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

23Andme Holding Systematic Risk

Today, most investors in 23Andme Holding Stock are looking for potential investment opportunities by analyzing not only static indicators but also various 23Andme Holding's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of 23Andme Holding growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of 23Andme Holding help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of 23Andme Holding Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of 23Andme Holding Co based on widely used predictive technical indicators. In general, we focus on analyzing 23Andme Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build 23Andme Holding's daily price indicators and compare them against related drivers.

When running 23Andme Holding's price analysis, check to measure 23Andme Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 23Andme Holding is operating at the current time. Most of 23Andme Holding's value examination focuses on studying past and present price action to predict the probability of 23Andme Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 23Andme Holding's price. Additionally, you may evaluate how the addition of 23Andme Holding to your portfolios can decrease your overall portfolio volatility.